Viewing Study NCT03914794

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:37 AM
Ignite Modification Date: 2026-03-05 @ 2:31 PM
Study NCT ID: NCT03914794
Status: COMPLETED
Last Update Posted: 2025-10-03
First Post: 2019-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None NMIBC View
None Non-Muscle Invasive Bladder Cancer View
None Urothelial Carcinoma Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pemigatinib View
None FGFR inhibitor View
None Bladder Cancer View
None Non Muscle Invasive Bladder Cancer View
None Non-Muscle Invasive Bladder Cancer (NMIBC) View
None NMIBC View
None Urothelial Carcinoma View
None Urothelial Cancer View
None Urinary Bladder Neoplasm View
None Bladder Neoplasm View
None Fibroblast inhibitors View